TSHA
NASDAQ · Biotechnology
Taysha Gene Therapies Inc
$4.33
+0.24 (+5.87%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
+1,305.5% upside
Low Target
$45.99
Average Target
$60.86
High Target
$68.15
Current Price
$4.33
Current
$4.33
$4.33
Target
$60.86
$60.86
$45.99
$60.86 avg
$68.15
Scenario Analysis
Bear Case
$45.99
962.1%
Low target
Base Case
$60.86
+1,305.5%
Avg target
Bull Case
$68.15
+1,473.9%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$7.30
-40.7% from high
52-Week Low
$3.46
+25.3% from low
Target vs 52W High
$60.86
+733.7% vs high
Next Earnings Report
Nov 12, 2026
2d
until earnings
EPS Est: $-0.13
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.2% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.8% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +114.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -20.2% |
| MRNA | Hold | 31 | 32% | $149.45 | -46.0% |
| REGN | Buy | 36 | 72% | $76.80 | -91.7% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.0% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -42.6% |